DOI:
10.1055/s-00000099
Zeitschrift für Orthopädie und Unfallchirurgie
LinksClose Window
References
Nilsson S, Franzén L, Parker C et al.
Bone-targeted radium-223 in symptomatic hormone-refractory prostate cancer; a randomised, multicentre, placebo-controlled phase II study.
Lancet Oncol 2007;
8: 587-594
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.